NT‐proBNP and changes in cognition and global brain structure: The Rotterdam Study
European Journal of Neurology · 2023
DOI: 10.1111/ene.15859 ↗At a glance
Journal article in European Journal of Neurology, 2023. Written by Tian Xiao and 7 co-authors. Institution: Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands. Major MEDLINE topics: Natriuretic Peptide, Brain, Cognition Disorders. Cited 12 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: ZonMw, Alzheimer Nederland, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (original language)
Objective
To investigate the association between N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) and changes in cognition and global brain structure.
Methods
In the Rotterdam Study, baseline NT‐proBNP was assessed at baseline from 1997 to 2008. Between 1997 and 2016, participants without dementia or stroke at baseline ( n = 9566) had repeated cognitive tests (every 3–6 years) for global cognitive function, executive cognitive function, fine manual dexterity, and memory. Magnetic resonance imaging of the brain was performed repeatedly at re‐examination visits between 2005 and 2015 for 2607 participants to obtain brain volumes, focal brain lesions, and white matter microstructural integrity as measures of brain structure.
Results
Among 9566 participants (mean age 65.1 ± 9.8 years), 5444 (56.9%) were women, and repeated measures of cognition were performed during a median follow‐up time of 5.5 (range 1.1–17.9) years, of whom 2607 participants completed at least one brain imaging scan. Higher levels of NT‐proBNP were associated with a faster decline of scores in the global cognitive function ( p value = 0.003) and the Word‐Fluency test ( p value = 0.003) but were not related to a steeper deterioration in brain volumes, global fractional anisotropy, and mean diffusivity, as indicators of white matter microstructural integrity, or focal brain lesions.
Conclusions
Higher baseline NT‐proBNP levels were associated with a faster decline in cognition; however, no association with global brain structure was found.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
- Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
- Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
ORCID profiles: Tian Xiao
Funding
- ZonMw
- Alzheimer Nederland
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Cite
APA
Xiao, T., van der Velpen, I. F., Niessen, W. J., Tilly, M. J., Kavousi, M., Ikram, M. A., Ikram, M. K., & Vernooij, M. W. (2023). NT‐proBNP and changes in cognition and global brain structure: The Rotterdam Study. European Journal of Neurology. https://doi.org/10.1111/ene.15859
Vancouver
Xiao T, van der Velpen IF, Niessen WJ, Tilly MJ, Kavousi M, Ikram MA, et al. NT‐proBNP and changes in cognition and global brain structure: The Rotterdam Study. European Journal of Neurology. 2023. doi:10.1111/ene.15859
BibTeX
@article{Xiao2023,
author = {Xiao, Tian and van der Velpen, Isabelle F and Niessen, Wiro J and Tilly, Martijn J and Kavousi, Maryam and Ikram, M Arfan and Ikram, M Kamran and Vernooij, Meike W},
title = {NT‐proBNP and changes in cognition and global brain structure: The Rotterdam Study},
journal = {European Journal of Neurology},
year = {2023},
doi = {10.1111/ene.15859}
}
EUVIMED